PAK

Signaling Pathway Map

Research Area

  • Inhibitory Selectivity
  • Solubility
Catalog No. Product Name Solubility(25°C)
Water DMSO Alcohol
S7093 IPA-3 <1 mg/mL 70 mg/mL 7 mg/mL
S7094 PF-3758309 <1 mg/mL 98 mg/mL 98 mg/mL
S8444 KPT-9274 <1 mg/mL 100 mg/mL 100 mg/mL
S7271 FRAX597 <1 mg/mL 14 mg/mL 1 mg/mL
S7807 FRAX486 <1 mg/mL 22 mg/mL <1 mg/mL
S7989 FRAX1036 <1 mg/mL <1 mg/mL 20 mg/mL

Isoform-specific Inhibitors

Catalog No. Information Product Use Citations Product Validations
S7093

IPA-3

IPA-3 is a selective non-ATP competitive Pak1 inhibitor with IC50 of 2.5 μM in a cell-free assay, no inhibition to group II PAKs (PAKs 4-6).

S7094

PF-3758309

PF-03758309 is a potent, ATP-competitive, pyrrolopyrazole inhibitor of PAK4 with IC50 of 1.3 nM.

S8444New

KPT-9274

KPT-9274 is an orally bioavailable small molecule that is a non-competitive dual inhibitor of PAK4 and NAMPT. It shows an IC50 of ~120 nM for NAMPT in a cell-free enzymatic assay.

S7271

FRAX597

FRAX597 is a potent, ATP-competitive inhibitor of group I PAKs with IC50 of 8 nM, 13 nM, and 19 nM for PAK1, PAK2, and PAK3, respectively.

S7807

FRAX486

FRAX486 is a potent p21-activated kinase (PAK) inhibitor with IC50 values of 14, 33, 39 and 575 nM for PAK1, PAK2, PAK3 and PAK4 respectively.

S7989

FRAX1036

FRAX-1036 is a potent and selective PAK inhibitor with biochemical potency (Ki) of 23.3 nM and 72.4 nM against PAK1 and PAK2.